Reliability of striatal [ 11C]raclopride binding in smokers wearing transdermal nicotine patches

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 39, Issue 2, 2012, Pages 220-225

  Yoder, Karmen K ^a,b   Albrecht, Daniel S ^a,b   Kareken, David A ^a,b   Federici, Lauren M ^a,b   Perry, Kevin M ^a,b   Patton, Elizabeth A ^a,b   Zheng, Qi Huang ^a,b   Mock, Bruce H ^a,b   O'Connor, Sean J ^b   Herring, Christine M ^a,b  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

11C raclopride; D 2receptor; Dopamine; Positron emission tomography; Test retest variability; Transdermal nicotine patch

Indexed keywords

DOPAMINE; NICOTINE PATCH; RACLOPRIDE C 11; CARBON; DOPAMINE 2 RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; NICOTINE GUM; RACLOPRIDE;

ADULT; ARTICLE; BINDING AFFINITY; CIGARETTE SMOKING; CORPUS STRIATUM; CORRELATION COEFFICIENT; HUMAN; MALE; POSITRON EMISSION TOMOGRAPHY; REPRODUCIBILITY; TEST RETEST RELIABILITY; WITHDRAWAL SYNDROME; CHEMISTRY; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; SMOKING;

ADULT; CARBON ISOTOPES; CORPUS STRIATUM; DOPAMINE; DOPAMINE ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RACLOPRIDE; RECEPTORS, DOPAMINE D2; REPRODUCIBILITY OF RESULTS; SMOKING; TOBACCO USE CESSATION PRODUCTS;

EID: 84859651481     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1965-z     Document Type: Article

References (35)

1. Egerton A, Mehta MA, Montgomery AJ, Lappin JM, Howes OD, Reeves SJ, et al. The dopaminergic basis of human behaviors: a review of molecular imaging studies. Neurosci Biobehav Rev 2009;33:1109-32. doi:10.1016/j.neubiorev.2009.05. 005.
2. Yoder KK, Kareken DA, Morris ED. Assessing dopaminergic neurotransmission with PET: basic theory and applications in alcohol research. Curr Med Imaging Rev 2011;7:118-24.
3. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 2000;20:423-51. (Pubitemid 30164887)
4. Morris ED, Yoder KK. Positron emission tomography displacement sensitivity: predicting binding potential change for positron emission tomography tracers based on their kinetic characteristics. J Cereb Blood Flow Metab 2007;27:606-17. doi:10.1038/sj.jcbfm.9600359.
5. Yoder KK, Kareken DA, Morris ED. What were they thinking? Cognitive states may influence [(11)C]raclopride binding potential in the striatum. Neurosci Lett 2008;430:38-42.
6. Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR, et al. Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 2006;26:6583-8.
7. Wong DF, Kuwabara H, Schretlen DJ, Bonson KR, Zhou Y, Nandi A, et al. Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving. Neuropsychopharmacology 2006;31:2716-27. (Pubitemid 44764168)
8. Brody AL, Mandelkern MA, Olmstead RE, Scheibal D, Hahn E, Shiraga S, et al. Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry 2006;63:808-16.
9. Brody AL, Olmstead RE, London ED, Farahi J, Meyer JH, Grossman P, et al. Smoking-induced ventral striatum dopamine release. Am J Psychiatry 2004;161:1211-8. (Pubitemid 38859170)
10. Heinz A, Siessmeier T, Wrase J, Hermann D, Klein S, Grüsser-Sinopoli SM, et al. Correlation between dopamine D(2) receptors in the ventral striatum and central processing of alcohol cues and craving. Am J Psychiatry 2004;161:1783-9. (Pubitemid 39314671)
11. Bucholz KK, Cadoret R, Cloninger CR, Dinwiddie SH, Hesselbrock VM, Nurnberger Jr JI, et al. A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. J Stud Alcohol 1994;55:149-58. (Pubitemid 24080088)
12. Pomerleau CS, Carton SM, Lutzke ML, Flessland KA, Pomerleau OF. Reliability of the Fagerstrom Tolerance Questionnaire and the Fagerstrom Test for Nicotine Dependence. Addict Behav 1994;19:33-9. (Pubitemid 24072190)
13. Yoder KK, Albrecht DS, Kareken DA, Federici LM, Perry KM, Patton EA, et al. Test-retest variability of [(11)C]raclopride-binding potential in nontreatment-seeking alcoholics. Synapse 2011;65:553-61. doi:10.1002/syn.20874.
14. Ramchandani VA, Bolane J, Li TK, O'Connor S. A physiologically-based pharmacokinetic (PBPK) model for alcohol facilitates rapid BrAC clamping. Alcohol Clin Exp Res 1999;23:617-23. (Pubitemid 29203217)
15. O'Connor S, Morzorati S, Christian J, Li TK. Clamping breath alcohol concentration reduces experimental variance: application to the study of acute tolerance to alcohol and alcohol elimination rate. Alcohol Clin Exp Res 1998;22:202-10. (Pubitemid 28139218)
16. Etter JF. A self-administered questionnaire to measure cigarette withdrawal symptoms: the Cigarette Withdrawal Scale. Nicotine Tob Res 2005;7:47-57. doi:10.1080/14622200412331328501.
17. Fei X, Mock BH, DeGrado TR, Wang JQ, Glick-Wilson BE, Sullivan ML, et al. An improved synthesis of PET dopamine D2 receptors radioligand [11C]raclopride. Synth Commun 2004;34:1897-907. (Pubitemid 38738401)
18. Yoder KK, Morris ED, Constantinescu CC, Cheng TE, Normandin MD, O'Connor SJ, et al. When what you see isn't what you get: alcohol cues, alcohol administration, prediction error, and human striatal dopamine. Alcohol Clin Exp Res 2009;33:139-49. doi:10.1111/j.1530-0277.2008.00821.x.
19. Martinez D, Slifstein M, Broft A, Mawlawi O, Hwang DR, Huang Y, et al. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 2003;23:285-300. (Pubitemid 36307573)
20. Mai JK, Assheuer J, Paxinos G. Atlas of the human brain. San Diego: Academic; 1997.
21. Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, et al. Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 2007;27:1533-9. doi:10.1038/sj.jcbfm.9600493. (Pubitemid 47301451)
22. Ichise M, Liow JS, Lu JQ, Takano A, Model K, Toyama H, et al. Linearized reference tissue parametric imaging methods: application to [11C]DASB positron emission tomography studies of the serotonin transporter in human brain. J Cereb Blood Flow Metab 2003;23:1096-112. doi:10.1097/01.WCB.0000085441.37552.CA. (Pubitemid 37082435)
23. McGraw KO, Wong SP. Forming inferences about some intraclass correlation coefficients. Psychol Methods 1996;1:30-46. (Pubitemid 126421252)
24. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420-8.
25. Hirvonen J, Aalto S, Lumme V, Någren K, Kajander J, Vilkman H, et al. Measurement of striatal and thalamic dopamine D2 receptor binding with 11C-raclopride. Nucl Med Commun 2003;24:1207-14. doi:10.1097/01.mnm.0000104642. 79626.e8. (Pubitemid 39619582)
26. Mawlawi O, Martinez D, Slifstein M, Broft A, Chatterjee R, Hwang DR, et al. Imaging human mesolimbic dopamine transmission with positron emission tomography: I. Accuracy and precision of D(2) receptor parameter measurements in ventral striatum. J Cereb Blood Flow Metab 2001;21:1034-57. (Pubitemid 32823740)
27. Volkow ND, Fowler JS, Wang GJ, Dewey SL, Schlyer D, MacGregor R, et al. Reproducibility of repeated measures of carbon-11-raclopride binding in the human brain. J Nucl Med 1993;34:609-13. (Pubitemid 23115661)
28. Hietala J, Någren K, Lehikoinen P, Ruotsalainen U, Syvälahti E. Measurement of striatal D2 dopamine receptor density and affinity with [11C]-raclopride in vivo: a test-retest analysis. J Cereb Blood Flow Metab 1999;19:210-7. (Pubitemid 29284269)
29. Schlösser R, Brodie JD, Dewey SL, Alexoff D, Wang GJ, Fowler JS, et al. Long-term stability of neurotransmitter activity investigated with 11C-raclopride PET. Synapse 1998;28:66-70. (Pubitemid 128770604)
30. Nisell M, Nomikos GG, Svensson TH. Infusion of nicotine in the ventral tegmental area or the nucleus accumbens of the rat differentially affects accumbal dopamine release. Pharmacol Toxicol 1994;75:348-52. (Pubitemid 24366267)
31. Schiffer WK, Gerasimov MR, Marsteller DA, Geiger J, Barnett C, Alexoff DL, et al. Topiramate selectively attenuates nicotine-induced increases in monoamine release. Synapse 2001;42:196-8. doi:10.1002/syn.10000. (Pubitemid 32999627)
32. Montgomery AJ, Lingford-Hughes AR, Egerton A, Nutt DJ, Grasby PM. The effect of nicotine on striatal dopamine release in man: a [11C]raclopride PET study. Synapse 2007;61:637-45. (Pubitemid 46934011)
33. Tsukada H, Miyasato K, Kakiuchi T, Nishiyama S, Harada N, Domino EF. Comparative effects of methamphetamine and nicotine on the striatal [(11)C]raclopride binding in unanesthetized monkeys. Synapse 2002;45:207-12. (Pubitemid 34827553)
34. Yoder KK, Kareken DA, Seyoum RA, O'Connor SJ, Wang C, Zheng QH, et al. Dopamine D(2) receptor availability is associated with subjective responses to alcohol. Alcohol Clin Exp Res 2005;29:965-70. (Pubitemid 40934200)
35. Yoder KK, Constantinescu CC, Kareken DA, Normandin MD, Cheng TE, O'Connor SJ, et al. Heterogeneous effects of alcohol on dopamine release in the striatum: a PET study. Alcohol Clin Exp Res 2007;31:965-73. (Pubitemid 46776176)